Seminar December 2021 – Professor Barenholz
On Friday, December 10, 2021, a seminar on "Liposomal Resolvin D1 for bone regeneration and treatment of osteoarthritis" was held at 11 a.m. (CET).
![Online Seminar Barenholz 2021-12](https://www.phospholipid-research-center.com/wp-content/uploads/2021/12/Online-Seminar-Barenholz-2021-12.png)
The speaker was Professor Dr. Yechezkel (Chezy) Barenholz from the Hebrew University of Jerusalem. Prof. Barenholz is one of the key inventors of Doxil®, the first FDA approved nano-drug (November 1995), marketed by Baxter for a cancer treatment. On October 2021, FDA approved a generic Doxil developed by Barenholz and his team.
If you need the slides of the presentation, please get in touch with us!